Legal & General Group PLC Stoke Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 37,486 shares of STOK stock, worth $453,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,486
Previous 37,486 -0.0%
Holding current value
$453,580
Previous $460,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$12.24 - $15.92 $12,448 - $16,190
1,017 Added 2.79%
37,486 $460,000
Q2 2024

Aug 14, 2024
BUY
$11.03 - $17.52 $377,126 - $599,026
34,191 Added 1500.92%
36,469 $492,000
Q1 2024

May 14, 2024
SELL
$4.12 - $14.17 $3,506 - $12,058
-851 Reduced 27.2%
2,278 $30,000
Q4 2023

Feb 15, 2024
SELL
$3.37 - $5.4 $26,302 - $42,147
-7,805 Reduced 71.38%
3,129 $16,000
Q3 2023

Nov 14, 2023
SELL
$3.78 - $11.99 $16,095 - $51,053
-4,258 Reduced 28.03%
10,934 $43,000
Q2 2023

Aug 14, 2023
BUY
$7.93 - $13.82 $94,930 - $165,439
11,971 Added 371.65%
15,192 $161,000
Q1 2023

May 15, 2023
SELL
$7.65 - $10.38 $23,539 - $31,939
-3,077 Reduced 48.86%
3,221 $26,000
Q3 2022

Nov 14, 2022
BUY
$12.56 - $22.53 $13,263 - $23,791
1,056 Added 20.14%
6,298 $81,000
Q2 2022

Aug 22, 2022
SELL
$10.36 - $23.93 $404 - $933
-39 Reduced 0.74%
5,242 $69,000
Q4 2021

Feb 14, 2022
BUY
$18.11 - $30.72 $525 - $890
29 Added 0.55%
5,281 $127,000
Q3 2021

Nov 15, 2021
BUY
$23.65 - $34.44 $59,881 - $87,202
2,532 Added 93.09%
5,252 $134,000
Q2 2021

Aug 12, 2021
BUY
$30.53 - $41.09 $21,828 - $29,379
715 Added 35.66%
2,720 $92,000
Q1 2021

May 17, 2021
BUY
$36.08 - $69.81 $7,937 - $15,358
220 Added 12.32%
2,005 $78,000
Q4 2020

Feb 12, 2021
SELL
$33.62 - $61.93 $18,659 - $34,371
-555 Reduced 23.72%
1,785 $110,000
Q3 2020

Nov 13, 2020
BUY
$22.23 - $37.48 $6,246 - $10,531
281 Added 13.65%
2,340 $79,000
Q2 2020

Aug 14, 2020
SELL
$20.26 - $29.73 $11,325 - $16,619
-559 Reduced 21.35%
2,059 $49,000
Q1 2020

May 14, 2020
BUY
$16.8 - $34.15 $13,708 - $27,866
816 Added 45.28%
2,618 $60,000
Q4 2019

Feb 13, 2020
BUY
$20.01 - $30.79 $6,243 - $9,606
312 Added 20.94%
1,802 $51,000
Q3 2019

Nov 13, 2019
BUY
$20.53 - $37.72 $30,589 - $56,202
1,490 New
1,490 $32,000

Others Institutions Holding STOK

# of Institutions
124
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $477M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email